DC Funds, LP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), DC Funds, LP reported 3 stock positions worth $1.3 million. Its top holding was Tscan Therapeutics (TCRX) at 49.3% of the portfolio, followed by Barinthus Biotherapeutics PL (BRNS, 33.8%) and Werewolf Therapeutics (HOWL, 16.9%). Its holdings were unchanged from Q1 2026.
- Most Recent 13F
- Q2 2026
- Location
- MCLEAN, VA
- CIK
- 0001869028
- Portfolio Value
- $1.3M (Q2 2026)
- SEC Filing
- 0001398344-26-014487 ↗ filed Aug 14, 2026
Holdings Value
Holdings 3 stocks · $1.3M
Portfolio Sells Q1 2026 → Q2 2026
| None this quarter. | |||
Portfolio Buys Q1 2026 → Q2 2026
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $1.3M | TCRX, BRNS, HOWL |
| Q1 2026 | 3 | $1.5M | TCRX, HOWL, BRNS |
| Q4 2025 | 3 | $1.5M | TCRX, BRNS, HOWL |
| Q3 2025 | 3 | $3.1M | HOWL, TCRX, BRNS |
| Q2 2025 | 3 | $2.2M | TCRX, HOWL, BRNS |
| Q1 2025 | 3 | $2.1M | TCRX, BRNS, HOWL |
| Q4 2024 | 3 | $3.6M | TCRX, HOWL, BRNS |
| Q3 2024 | 3 | $5.2M | TCRX, HOWL, BRNS |
| Q2 2024 | 3 | $6.0M | TCRX, HOWL, BRNS |
| Q1 2024 | 3 | $10.3M | TCRX, HOWL, BRNS |